Use of citrulline peptides derived from filaggrin for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/17 (2006.01) C07K 14/47 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2315294

The invention concerns the use of a citrulline peptide antigen derived from filaggrin to obtain medicines for treating rheumatoid arthritis.

L'invention est relative à l'utilisation d'un antigène peptidique citrulliné dérivé de la filaggrine, pour l'obtention de médicaments destinés au traitement de la polyarthrite rhumatoïde.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of citrulline peptides derived from filaggrin for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of citrulline peptides derived from filaggrin for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of citrulline peptides derived from filaggrin for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1452800

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.